Your browser doesn't support javascript.
loading
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study.
Rimini, Margherita; Shimose, Shigeo; Lonardi, Sara; Tada, Toshifumi; Masi, Gianluca; Iwamoto, Hideki; Lai, Eleonora; Burgio, Valentina; Hiraoka, Atsushi; Ishikawa, Toru; Soldà, Caterina; Shirono, Tomotake; Vivaldi, Caterina; Takaguchi, Koichi; Shimada, Noritomo; Astara, Giorgio; Koga, Hironori; Nouso, Kazuhiro; Joko, Kouji; Torimura, Takuji; Hiasa, Yoichi; Salani, Francesca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea.
Afiliação
  • Rimini M; Division of Oncology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy.
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Lonardi S; Early Phase Clinical Trial Unit, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Tada T; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Masi G; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.
  • Iwamoto H; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Lai E; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Burgio V; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Hiraoka A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Ishikawa T; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Soldà C; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Shirono T; Medical Oncology Unit 1, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Vivaldi C; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Takaguchi K; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Shimada N; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Astara G; Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan.
  • Koga H; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Nouso K; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Joko K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Torimura T; Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Hiasa Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Salani F; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Matsuyama, Japan.
  • Scartozzi M; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Cascinu S; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Casadei-Gardini A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
Hepatol Res ; 51(12): 1229-1241, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34591334
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article